Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock

被引:23
作者
Jochberger, S.
Luckner, G.
Mayr, V. D.
Wenzel, V.
Morgenthaler, N. G.
Friesenecker, B. E.
Hasibeder, W. R.
Duenser, M. W.
机构
[1] Innsbruck Med Univ, Dept Anesthesiol, A-6020 Innsbruck, Austria
[2] Hosp Merciful Sisters, Dept Anesthesiol & Crit Care Med, Ried, Austria
[3] BRAHMS Aktiengesell, Dept Res, Hennigsdorf, Germany
关键词
arginine vasopressin; copeptin; plasma concentrations; sepsis; septic shock;
D O I
10.1177/0310057X0603400415
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
In this case report, the course of arginine vasopressin and copeptin, the stable C-terminal part of the arginine vasopressin precursor, is described during the period of critical illness in a septic shock patient. Arginine vasopressin and copeptin concentrations were substantially increased during the initial 36 hours of shock. Subsequently, both hormones continuously decreased, but exhibited another peak in response to stress during extubation. During restoration of cardiovascular stability, endogenous arginine vasopressin levels further decreased and obviously did not contribute to haemodynamic improvement. In contrast, the decrease in arginine vasopressin and copeptin can be at least partly explained by an improvement of cardiovascular function.
引用
收藏
页码:498 / 500
页数:3
相关论文
共 14 条
[1]   Vasopressin receptors [J].
Birnbaumer, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (10) :406-410
[2]  
Groeneveld ABJ, 1999, SHOCK, V11, P160
[3]   Serum vasopressin concentrations in critically ill patients [J].
Jochberger, S ;
Mayr, VD ;
Luckner, G ;
Wenzel, V ;
Ulmer, H ;
Schmid, S ;
Knotzer, H ;
Pajk, W ;
Hasibeder, W ;
Friesenecker, B ;
Mayr, AJ ;
Dünser, MW .
CRITICAL CARE MEDICINE, 2006, 34 (02) :293-299
[4]  
Landry DW, 1997, CIRCULATION, V95, P1122
[5]   Mechanisms of disease: The pathogenesis of vasodilatory shock [J].
Landry, DW ;
Oliver, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (08) :588-595
[6]   Cardiovascular response to dopamine and early prediction of outcome in septic shock: A prospective multiple-center study [J].
Levy, B ;
Dusang, B ;
Annane, D ;
Gibot, S ;
Bollaert, PE .
CRITICAL CARE MEDICINE, 2005, 33 (10) :2172-2177
[7]   Low-dose vasopressin in the treatment of vasodilatory septic shock [J].
Malay, MB ;
Ashton, RC ;
Landry, DW ;
Townsend, RN .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1999, 47 (04) :699-703
[8]   Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin [J].
Morgenthaler, NG ;
Struck, J ;
Alonso, C ;
Bergmann, A .
CLINICAL CHEMISTRY, 2006, 52 (01) :112-119
[9]   Role of vasopressin in the management of septic shock [J].
Mutlu, GM ;
Factor, P .
INTENSIVE CARE MEDICINE, 2004, 30 (07) :1276-1291
[10]   Potassium channels and septic shock [J].
Oliver, JA ;
Landry, DW .
CRITICAL CARE MEDICINE, 2006, 34 (04) :1255-1257